This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
BA Arnow , C Blasey , R Manber , MJ Constantino , JC Markowitz , DN Klein , ME Thase , JH Kocsis , AJ Rush (2007). Dropouts versus completers among chronically depressed outpatients. Journal of Affective Disorders 97, 197–202.
LA Cooper , JJ Gonzales , JJ Gallo , KM Rost , LS Meredith , LV Rubenstein , NY Wang , DE Ford (2003). The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Medical Care 41, 479–489.
K Demyttenaere , E Van Ganse , J Gregoire , E Gaens , P Mesters (1998). Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group. International Clinical Psychopharmacology 13, 11–17.
M Dwight-Johnson , CD Sherbourne , D Liao , KB Wells (2000). Treatment preferences among depressed primary care patients. Journal of General Internal Medicine 15, 527–534.
J Endicott , J Nee , W Harrison , R Blumenthal (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology Bulletin 29, 321–326.
M Fava , JE Alpert , CN Carmin , SR Wisniewski , MH Trivedi , MM Biggs , K Shores-Wilson , D Morgan , T Schwartz , GK Balasubramani , AJ Rush (2004). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine 34, 1299–1308.
M Fava , AJ Rush , MH Trivedi , AA Nierenberg , ME Thase , HA Sackeim , FM Quitkin , S Wisniewski , PW Lavori , JF Rosenbaum , DJ Kupfer (2003). Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatric Clinics of North America 26, 457–494.
M Hamilton (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56–62.
M Hamilton (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278–296.
RM Hirschfeld , DL Dunner , G Keitner , DN Klein , LM Koran , SG Kornstein , JC Markowitz , I Miller , CB Nemeroff , PT Ninan , (2002). Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biological Psychiatry 51, 123–133.
AY Khan , J Carrithers , SH Preskorn , R Lear , SR Wisniewski , AJ Rush , D Stegman , C Kelley , K Kreiner , AA Nierenberg , M Fava (2006). Clinical and demographic factors associated with DSM-IV melancholic depression. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 18, 91–98.
BS Linn , MW Linn , L Gurel (1968). Cumulative illness rating scale. Journal of the American Geriatrics Society 16, 622–626.
CA Melfi , AJ Chawla , TW Croghan , MP Hanna , S Kennedy , K Sredl (1998). The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Archives of General Psychiatry 55, 1128–1132.
MD Miller , CF Paradis , PR Houck , S Mazumdar , JA Stack , AH Rifai , B Mulsant , III CF Reynolds (1992). Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Research 41, 237–248.
JC Mundt , IM Marks , MK Shear , JH Greist (2002). The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 180, 461–464.
JS Novick , JW Stewart , SR Wisniewski , IA Cook , R Manev , AA Nierenberg , JF Rosenbaum , K Shores-Wilson , GK Balasubramani , MM Biggs , S Zisook , AJ Rush (2005). Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. Journal of Clinical Psychiatry 66, 1002–1011.
AJ Rush , IH Bernstein , MH Trivedi , TJ Carmody , S Wisniewski , JC Mundt , K Shores-Wilson , MM Biggs , A Woo , AA Nierenberg , M Fava (2006a). An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a Sequenced Treatment Alternatives to Relieve Depression trial report. Biological Psychiatry 59, 493–501.
AJ Rush , TJ Carmody , PE Reimitz (2000). The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research 9, 45–59.
AJ Rush , M Fava , SR Wisniewski , PW Lavori , MH Trivedi , HA Sackeim , ME Thase , AA Nierenberg , FM Quitkin , TM Kashner , (2004). Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Controlled Clinical Trials 25, 119–142.
AJ Rush , CM Gullion , MR Basco , RB Jarrett , MH Trivedi (1996). The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 26, 477–486.
AJ Rush , HC Kraemer , HA Sackeim , M Fava , MH Trivedi , E Frank , PT Ninan , ME Thase , AJ Gelenberg , DJ Kupfer , (2006b). Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder. Neuropsychopharmacology 31, 1841–1853.
AJ Rush , MH Trivedi , HM Ibrahim , TJ Carmody , B Arnow , DN Klein , JC Markowitz , PT Ninan , S Kornstein , R Manber , (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573–583 [Erratum, p. 585].
AJ Rush , MH Trivedi , SR Wisniewski , JW Stewart , AA Nierenberg , ME Thase , L Ritz , MM Biggs , D Warden , JF Luther , (2006c). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine 354, 1231–1242.
AJ Rush , M Zimmerman , SR Wisniewski , M Fava , SD Hollon , D Warden , MM Biggs , K Shores-Wilson , RC Shelton , JF Luther , (2005). Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. Journal of Affective Disorders 87, 43–55.
JR Tedlow , M Fava , LA Uebelacker , JE Alpert , AA Nierenberg , JF Rosenbaum (1996). Are study dropouts different from completers? Biological Psychiatry 40, 668–670.
MH Trivedi , M Fava , SR Wisniewski , ME Thase , F Quitkin , D Warden , L Ritz , AA Nierenberg , BD Lebowitz , MM Biggs , (2006a). Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine 354, 1243–1252.
MH Trivedi , AJ Rush , BN Gaynes , JW Stewart , SR Wisniewski , D Warden , L Ritz , JF Luther , D Stegman , J DeVeaugh-Geiss , R Howland (2007). Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology 32, 2479–2489.
MH Trivedi , AJ Rush , HM Ibrahim , TJ Carmody , MM Biggs , T Suppes , ML Crismon , K Shores-Wilson , MG Toprac , EB Dennehy , (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 34, 73–82.
MH Trivedi , AJ Rush , SR Wisniewski , AA Nierenberg , D Warden , L Ritz , G Norquist , RH Howland , B Lebowitz , PJ McGrath , (2006b). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 163, 28–40.
D Warden , MH Trivedi , SR Wisniewski , L Davis , AA Nierenberg , BN Gaynes , S Zisook , SD Hollon , GK Balasubramani , R Howland , (2007). Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. American Journal of Psychiatry 164, 1189–1197.
JE Ware , M Kosinski , SD Keller (1996). A 12-item Short-Form Health Survey. Construction of scales and preliminary tests of reliability and validity. Medical Care 34, 220–233.
SR Wisniewski , H Eng , L Meloro , R Gatt , L Ritz , D Stegman , M Trivedi , MM Biggs , E Friedman , K Shores-Wilson , (2004). Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. Clinical Trials (London, England) 1, 387–398.
SR Wisniewski , M Fava , MH Trivedi , ME Thase , D Warden , G Niederehe , ES Friedman , MM Biggs , HA Sackeim , K Shores-Wilson , (2007). Acceptability of second-step treatments to depressed outpatients: a STAR*D report. American Journal of Psychiatry 164, 753–760.
SR Wisniewski , AJ Rush , GK Balasubramani , MH Trivedi , AA Nierenberg (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice 12, 71–79.
M Zimmerman , JI Mattia (2001a). A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry 58, 787–794.
M Zimmerman , JI Mattia (2001b). The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Comprehensive Psychiatry 42, 175–189.